You just read:

Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress

News provided by

Neurocrine Biosciences, Inc.

Oct 04, 2019, 18:00 ET